Summary of Key Points Core Viewpoint - The Hong Kong stock market experienced significant net inflows from northbound trading, indicating a positive sentiment among investors towards certain stocks and sectors, particularly technology and ETFs [1][6]. Group 1: Northbound Trading Activity - Northbound trading recorded a net buy of HKD 234.26 billion, with HKD 139.36 billion from the Shanghai Stock Connect and HKD 94.89 billion from the Shenzhen Stock Connect [1]. - The most purchased stocks included the Tracker Fund of Hong Kong (盈富基金, 02800), Tencent (00700), and the Southern Hang Seng Technology ETF (南方恒生科技, 03033) [1][6]. - The stock with the highest net sell was Guotai Junan International (国泰君安国际, 01788), with a net outflow of HKD 50.72 million [1][9]. Group 2: Individual Stock Performance - The Tracker Fund of Hong Kong (02800) saw a net inflow of HKD 62.93 billion, while Tencent (00700) had a net inflow of HKD 5.26 billion [2]. - Other notable net inflows included InnoCare Pharma (英诺赛科, 02577) with HKD 2.33 billion, and Alibaba (阿里巴巴-W, 09988) with HKD 2.57 billion [2][8]. - Li Auto (理想汽车-W, 02015) received a net inflow of HKD 5.86 billion following an announcement of configuration adjustments for its i8 model [7]. Group 3: Sector Insights - The technology sector, which constitutes nearly one-third of the Hong Kong market, is expected to undergo a revaluation driven by improving fundamentals and policy expectations [6]. - Companies like Meitu (美图公司, 01357) reported a projected net profit increase of 65% to 72% year-on-year, indicating strong operational performance [7]. - UBS highlighted the potential of Akeso's core product AK112 in various cancer treatments, projecting significant revenue contributions from upcoming clinical trials [8].

Group 1 - The core point of the news is that the Hong Kong stock market saw significant net inflows from Northbound trading, with a total net buy of HKD 131.26 billion on July 31, 2023, indicating strong investor interest in certain stocks [1] - The most actively bought stocks included the Tracker Fund of Hong Kong (02800), Hang Seng China Enterprises (02828), and Meituan-W (03690), while the most sold stocks were Laopuhuangjin (06181), CSPC Pharmaceutical Group (01093), and Shandong Molong (00568) [1][2] - The Northbound trading saw net purchases of HKD 76.04 billion through the Shanghai Stock Connect and HKD 55.22 billion through the Shenzhen Stock Connect [1] Group 2 - The Tracker Fund of Hong Kong (02800) received a net buy of HKD 24.05 billion, while Hang Seng China Enterprises (02828) and Southern Hang Seng Technology (03033) received net buys of HKD 17.81 billion and HKD 9.73 billion, respectively [5] - Meituan-W (03690) and Kuaishou-W (01024) were also popular among investors, with net buys of HKD 13.98 billion and HKD 13.82 billion, respectively [5] - Semiconductor company SMIC (00981) received a net buy of HKD 2.21 billion, while Meituan (01357) saw a net buy of HKD 15.3 million, following a significant target price increase by Morgan Stanley [6] Group 3 - Laopuhuangjin (06181) faced a net sell of HKD 2.78 billion, with concerns about the sustainability of its profit growth [7] - Xiaomi Group-W (01810) received a net buy of HKD 4.41 billion, while CSPC Pharmaceutical Group (01093) and Shandong Molong (00568) experienced net sells of HKD 1.13 billion and HKD 371 million, respectively [7]